Reuters logo
BRIEF-Horizon Pharma reports Q3 loss per share of $0.04
November 7, 2016 / 12:28 PM / a year ago

BRIEF-Horizon Pharma reports Q3 loss per share of $0.04

Nov 7 (Reuters) - Horizon Pharma Plc

* Horizon Pharma - confirming full-year 2016 gaap net sales, non-GAAP adjusted net sales and adjusted EBITDA guidance

* FY2016 revenue view $1.03 billion -- Thomson Reuters I/B/E/S

* Horizon Pharma announces third-quarter 2016 financial results

* Q3 sales $208.7 million

* Q3 revenue view $270 million -- Thomson Reuters I/B/E/S

* Q3 non-GAAP earnings per share $0.70

* Q3 GAAP loss per share $0.04

* Q3 earnings per share view $0.63 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below